NIH-funded research R01 grant

Understanding how genetics influence blood clotting factors

Official title: Analysis of Whole Genome Sequence and Hemostasis Phenotypes

Funded at University of Texas Hlth Sci Ctr Houston · NIH-10849923 · Data updated 2026-11-12

This study is looking at how our genes affect important proteins that help our blood clot, specifically in a diverse group of 14,000 Hispanic people, to better understand blood clotting issues and improve health for everyone.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startJuly 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$640,459
NIH project number5R01HL139553-05
Project IDNIH-10849923 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals of Hispanic descent who may have variations in blood coagulation factors.

Less likely to help

Patients who do not have any genetic predisposition to thrombotic diseases or those outside the Hispanic population may not benefit from this research.

What this research studies

This research investigates the genetic and epigenetic factors that regulate coagulation factor VIII (FVIII) and von Willebrand factor (VWF), which are crucial for blood clotting. By analyzing whole genome sequences from a diverse group of 14,000 Hispanic participants, the study aims to identify new genetic loci associated with FVIII and VWF levels. The research employs advanced methodologies, including Mendelian randomization, to explore how these factors contribute to thrombotic diseases. The goal is to fill knowledge gaps in the genetics of blood coagulation, particularly in underrepresented populations.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment of thrombotic diseases, potentially reducing the risk of blood clots in patients.

How similar studies have gone: Previous research has successfully identified genetic determinants of blood coagulation factors, indicating that this approach has potential for meaningful discoveries.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Morrison, Alanna C — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Morrison, Alanna C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.